Black Titan Corporation - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
BTTC Nasdaq 2834

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Black Titan Corporation

Institutional Access via Public Equities: Black Titan's Strategic Pivot - Jan 23rd, 2026 8:00 am
Early & Accessible Investing - Jan 20th, 2026 1:00 pm
Digital-First Banking & Payments - Jan 20th, 2026 10:00 am
Black Titan Secures $200 Million from a U.S.-Based Institutional Investor to Scale Its DAT+ Vision - Jan 16th, 2026 7:00 pm
Black Titan Announces DAT+ Liquidity and Operational Readiness Pillar to Support Institutional-Grade Digital Asset Engagement - Dec 11th, 2025 11:30 am
Black Titan Introduces DAT+ Collaborative Engagement Pillar to Support High-Value Decentralized Ecosystems - Dec 11th, 2025 10:00 am
Black Titan Releases DAT+ Earnings Alignment Pillar Highlighting How Token Utility Interfaces With Economic Activity - Dec 11th, 2025 8:30 am
Black Titan Outlines DAT+ Risk Management Pillar Focused on Diversification and Institutional Oversight - Dec 11th, 2025 7:30 am
Black Titan Introduces DAT+ and Releases First Pillar Focused on Utility-Driven Digital Asset Participation - Dec 11th, 2025 6:30 am
Titan Pharmaceuticals, Inc. Announces Closing of Merger with Black Titan Corporation - Oct 3rd, 2025 3:26 pm